PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune ...

The following is a summary of “Minimal change glomerular disease associated with solid neoplasms: a systematic review,” ...

PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular diseases, supported by the disease-modifying potential of ...

The Phase 2 basket study will evaluate WAL0921 in individuals with glomerular kidney diseases and proteinuria. This study will enroll subjects with diabetic nephropathy (DN) and rare glomerular kidney ...

After several years of treatment with prednisone and cyclosporine, along with an ACE inhibitor, I was in "remission" and listed as stage 3. At the time, the life expectancy of someone with FSGS was 10 ...

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary ...

Chronic kidney disease (CKD) affects >850 million people globally and is an important risk factor for cardiovascular disease ...

Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.

Obesity, uncontrolled diabetes and hypertension are the main risk factors for the development of kidney diseases. In this ...

For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, metabolic surgery is associated with a lower risk for progression of kidney ...

The addition of belimumab to standard of care lupus nephritis induction therapy appears effective in real-world patients.